Question
What insurance covers laboratory billing and coding errors, payor audits, and False Claims Act exposure?
Short answer
Not the policies most labs assume. General liability does not respond to a billing dispute, and a professional liability form written around diagnostic accuracy often does not either. The exposure is usually addressed through billing errors and omissions coverage, regulatory or audit defense cover, and the management liability tower. Fines and penalties, and any amount that represents money you were not entitled to keep, are generally not insurable.
Why the usual policies do not answer this
A laboratory buys general liability for bodily injury and property damage, and professional liability for errors in testing and reporting. A billing dispute is neither. It is an allegation about a claim submitted for payment, and the loss is repayment plus defense rather than injury to a patient.
That is why an audit letter often lands with a lab that has a well-built programme and still has nothing that clearly responds. The gap is structural, not a symptom of buying cheap cover.
What the exposure actually looks like
It usually begins administratively rather than legally: a payor audit, a documentation request, a prepayment review, or an overpayment demand. The immediate costs are legal and consulting time, the burden of producing records, and cash flow disruption if payments are suspended while the review runs.
The serious version is a False Claims Act matter, which can be brought by the government or initiated by a whistleblower, frequently a current or former employee in billing or operations. The statute carries treble damages and per-claim penalties, which is why a volume business like a clinical laboratory can face an exposure far out of proportion to the underlying billing error.
What can be covered and what cannot
Defense costs are the insurable core. Billing errors and omissions coverage, and audit or regulatory defense extensions, are built to fund the response to an audit or investigation, and this is where the coverage earns its place.
What is generally not insurable is the return of money you were not entitled to. Restitution and disgorgement of overpayments are typically excluded or fall outside the definition of loss, and civil penalties are insurable only where law permits. Any presentation suggesting a policy will simply absorb a False Claims Act judgment should be read very carefully.
The management liability tower matters here too, because these matters frequently name individuals. Directors and officers coverage and employment practices liability are both commonly implicated, the latter because whistleblower retaliation claims often travel alongside the underlying allegation.
Automated and AI-assisted coding changes the analysis
Labs are increasingly adopting software that assigns or suggests codes. Delegating the task does not delegate the liability: the claim is still submitted in the laboratory’s name and under its provider number.
The specific risk is a systematic one. A human coder makes scattered errors; a misconfigured rule engine makes the same error across every claim it touches, which converts an isolated mistake into a pattern across a period. Patterns are what audits find and what supports an allegation of knowing conduct.
Two practical controls follow. Keep human review over automated output and keep evidence that you did, because a documented review process is the strongest answer to a knowledge allegation. And check whether the vendor agreement gives you any meaningful indemnity, and whether the vendor carries technology errors and omissions cover, since most such agreements cap liability well below the exposure they create.
What to ask for at renewal
Ask three questions. Does anything in the current programme fund the defense of a payor audit or a government investigation. Are individuals covered when they are named personally. And is the retention realistic against the cost of a document-heavy audit response, which is usually where the real spend sits.
A laboratory with meaningful federal or commercial payor volume and no answer to the first question has a gap worth closing before an audit letter arrives, because coverage bought after notice of a matter will not reach back to it.
Primary sources
Sources and references
This answer draws on the following regulatory, statutory, and standards-body sources. Coverage availability and program structure also depend on carrier appetite and underwriter discretion not captured by these sources.
- HHS Office of Inspector General - Fraud and Abuse Lawshttps://oig.hhs.gov/compliance/physician-education/fraud-abuse-laws/
- 31 U.S.C. 3729 - False Claims Acthttps://www.law.cornell.edu/uscode/text/31/3729
- CMS - Clinical Laboratory Improvement Amendments (CLIA)https://www.cms.gov/medicare/quality/clinical-laboratory-improvement-amendments
Related practice areas
Insurance clauses in this area
Related questions
- What insurance does a CLIA-certified clinical laboratory need?
- Is the referring laboratory still liable when it sends a test out to a reference lab?
- Does cyber insurance respond to an OCR HIPAA enforcement action when there was no breach?
- Does a life sciences company with employees need employment practices liability (EPLI) insurance?
Have a more specific question?
A specialist will reach out by the end of the day.
Request a free coverage review